Rx – Phase I to IV
International HealthCare (IHC) has the specialized experience and expertise in designing clinical trials in all phases of drug development.
The following is a brief overview of IHC’s experience:
IHC’s clinical staff of researchers is comprised of experts in many different therapeutic areas, including Vascular and Infectious Disease. Read more…
Our staff’s breadth of research experience in this therapeutic area encompasses the full range of planning and executing pain management trials. Read more…
The International HealthCare staff has conducted major clinical programs for the H2-antagonists, antacids, PPIs, and various other GI products. Our broad experience covers the full range of study designs (In-Use, provocative meal, motility, ulcer, IBS, GERD…). For more information, review our white paper on the Treatment for Diahrrea & Constipation.
IHC’s management team has broad experience in the entire CNS therapeutic area. Our staff was responsible for the project management, monitoring and closeout of an entire international program for a leading Alzheimer’s drug. This program involved multiple trials in over 450 centers in 18 countries. Our staff was responsible for the clinical monitoring, review, and data collection from each country, and for managing the quality control of all ongoing and closed data. We have experience designing and successfully implementing Web-based applications that provide total project management and quality control services.
IHC’s expertise covers a wide range of drugs and disease states, such as: cardiology (please see our Cardiovascular Profile news release), women’s health, neutraceuticals, dermatology and rheumatology. When success is critical, experience is mandatory.
- Hepatorenal Syndrome
- Intra-Occular Pressure